Article
A novel type 2A von Willebrand factor mutation (V1499E) associated with variable clinical expression.
Journal of pediatric hematology/oncology - 1 Apr 2009
van den Heuvel Esther, de Laat Bas, Eckmann Carel M, Michiels Jan J, Schneppenheim Reinhard, Budde Ulrich, van Mourik Jan A, Versteegh Florens G A
Abstract excerpt
We have identified a previously unreported mutation, V1499E, with a high penetrance in a family with type 2A von Willebrand disease. Affected family members were difficult to identify owing to variable von Willebrand factor (VWF) levels, variable expression of VWF multimers, and clinical symptoms. Recombinant V1499E-VWF was more readily cleaved by ADAMTS13 than the wild-type protein, suggesting that V1499E is the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
